Join Today and Give Back

What Clinical Trials Can Teach Us

September 7, 2022


Read time:

5-15 mins
Person Silhouette Throat Target Bullseye
Presented by Health Lab

A clinical trial in head and neck cancer explored ways to improve clinical outcomes for patients, and although the trial failed, researchers found insight into new ways to address treatment resistance. Treatment is limited, relying on aggressive surgery and insufficient therapeutics, which leaves patients with few options; researchers at the University of Michigan Rogel Cancer Center have been searching for ways to fundamentally change the approach to treating laryngeal cancer. Paul Swiecicki, M.D., clinical associate professor in medical oncology, says that Michigan Medicine was instrumental in changing this therapeutic course and discusses new ways to treat head and neck cancer.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.